Charles River Laboratories International (CRL) Shares Outstanding (Diluted Average) (2016 - 2025)

Charles River Laboratories International's Shares Outstanding (Diluted Average) history runs 10 years deep, the most recent figure standing at $49.6 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Diluted Average) fell 4.0% year-over-year to $49.6 million; the TTM figure through Dec 2025 stood at $49.6 million (down 4.0% YoY), while the FY2025 annual figure was $49.6 million, down 4.0% from the prior year.
• Shares Outstanding (Diluted Average) was $49.6 million for Q4 2025 at Charles River Laboratories International, roughly flat from $49.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $51.8 million in Q2 2024 to a low of $49.4 million in Q3 2025.
• Historically, Shares Outstanding (Diluted Average) has averaged $51.2 million across 5 years, with a median of $51.4 million in 2021.
• The sharpest annual moves came in 2021 and 2025: Shares Outstanding (Diluted Average) advanced 2.22% in 2021, then fell 4.42% in 2025.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $51.4 million in 2021, then retreated by 0.24% to $51.3 million in 2022, then rose by 0.29% to $51.5 million in 2023, then grew by 0.34% to $51.6 million in 2024, then retreated by 4.0% to $49.6 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $49.6 million (Q4 2025), $49.4 million (Q3 2025), and $50.1 million (Q2 2025), per Business Quant data.